CB47782-24 - 0x000000000000690E

Healthy Males & Females

Mesmerize

* Stipend may pay up to reflected amount.
Start Date: 
October 27, 2026 - 3:00pm
End Date: 
November 25, 2026 - 9:00am

Study Details

Study Number: CB47782
Group Number: 24
Study Requirement: Healthy Normal Male and Female
Stipend: up to $11,750.00

Study Criteria

Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat schizophrenia.
Route of Administration: Oral
Blood Draws: 51

Study Schedule

Schedule Type: Long Term
Study Length: 17 Night Stay & 2 Returns

Screening Dates:

Event Day Event Date
Monday 10/19/2026
Tuesday 10/20/2026
Friday 10/23/2026
Monday 10/26/2026
Tuesday 10/27/2026

Doctor Exam Dates:

Event Day Event Date
Monday 10/19/2026
Tuesday 10/20/2026
Friday 10/23/2026
Monday 10/26/2026
Tuesday 10/27/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Tuesday 10/27/2026 3:00:00 PM Friday 11/13/2026 9:00:00 AM 1 Lincoln
Return Wednesday 11/18/2026 7:30:00 AM Wednesday 11/18/2026 9:00:00 AM 1 Lincoln
Return Wednesday 11/25/2026 7:30:00 AM Wednesday 11/25/2026 9:00:00 AM 1 Lincoln